Company intelligence / Profile preview

See-Mode Technologies

Melbourne, Victoria, Australiasee-mode.com ↗

Ownership: Private
Employees: ~24
Development stage: Other

Overview

See‑Mode’s AVA platform has received multiple regulatory approvals—including FDA 510(k) clearance—for automated analysis and reporting of vascular ultrasound scans. The technology is also approved for breast and thyroid lesion analysis using AI to improve accuracy and efficiency in radiology workflows. Clinical validation studies supported these approvals.

Therapeutic areas: OncologyCardiovascularEndocrinology
Modalities: Device (medical software)Artificial Intelligence (AI)
Industry: Medical Imaging

Partnerships

Blackford Analysis – distribution partnership to offer See‑Mode solutions on Blackford’s imaging platformMultiple clinical collaborations with leading hospitals/radiology networks in Australia/Singapore/US/EU as part of product validation

Beyond the preview

Go deeper on See-Mode Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on See-Mode Technologies.

Explore the full profile